The Infection Connection in Schizophrenia

Adapted from image by I.I. Gottesman ©2001  GENES AND MORE: The risks of developing schizophrenia over a lifetime to the relatives of schizophrenia sufferers accord with a largely genetic explanation. Yet with 48% concordance for identical twins, environmental factors may play a role. It's a scary thought that one could develop a debilitating mental illness such as schizophrenia as easily as catching a cold. Well, it's more complicated than that, say advocates of the so-called infec

Written byBrendan Maher
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

It's a scary thought that one could develop a debilitating mental illness such as schizophrenia as easily as catching a cold. Well, it's more complicated than that, say advocates of the so-called infectious hypothesis, which states that viral and possibly bacterial infections occurring at critical points in brain development could increase the risk of mental illness. Everything from influenza to herpes simplex viruses to Toxoplasma gondii has been implicated in elevating risk for schizophrenia, perhaps indirectly through immunological reactions that change brain chemistry or wiring at key developmental stages. Raised, ridiculed, retracted, and rewrought, the hypothesis has morphed for nearly a century.

Its current permutation may be gaining ground, though. With better epidemiological studies and animal work emerging, some former scoffers are beginning to accept the notion that, while not a direct cause, infections may factor into schizophrenia's complex gene/environment formula that dictates one's chances for landing somewhere among the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies